Kala Advances Trials of Eye Drugs with $22.5M Financing – Drug Discovery & Development

Kala Advances Trials of Eye Drugs with $22.5M Financing
Drug Discovery & Development
This approach has yielded game-changing clinical-stage product candidates that may provide more convenient dosing for patients and improve efficacy in a range of ophthalmic indications, including dry eye disease and wet age-related macular degeneration

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment